John Reckless

2.1k total citations
57 papers, 1.5k citations indexed

About

John Reckless is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, John Reckless has authored 57 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Surgery, 18 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Physiology. Recurrent topics in John Reckless's work include Lipoproteins and Cardiovascular Health (24 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers) and Diet and metabolism studies (8 papers). John Reckless is often cited by papers focused on Lipoproteins and Cardiovascular Health (24 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers) and Diet and metabolism studies (8 papers). John Reckless collaborates with scholars based in United Kingdom, United States and Germany. John Reckless's co-authors include Rasha Mukhtar, Michael E. J. Lean, Eran Leitersdorf, Winfried März, Hallvard Holdaas, Rachel Laws, Terry A. Jacobson, Evan A. Stein, Christie M. Ballantyne and Michael H. Davidson and has published in prestigious journals such as The Lancet, PLoS ONE and Diabetes Care.

In The Last Decade

John Reckless

53 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Reckless United Kingdom 18 754 373 225 204 201 57 1.5k
S.M. Sadikot India 12 533 0.7× 646 1.7× 82 0.4× 107 0.5× 264 1.3× 32 1.7k
P.N. Durrington United Kingdom 16 577 0.8× 642 1.7× 83 0.4× 34 0.2× 149 0.7× 35 1.2k
Andrew M. Tershakovec United States 31 1.4k 1.9× 572 1.5× 550 2.4× 147 0.7× 617 3.1× 115 2.8k
Alice Dowdy United States 13 1.1k 1.5× 977 2.6× 163 0.7× 26 0.1× 256 1.3× 17 2.1k
Anna Tavridou Greece 22 371 0.5× 526 1.4× 72 0.3× 46 0.2× 218 1.1× 70 2.0k
Kathleen Wyne United States 21 986 1.3× 994 2.7× 147 0.7× 50 0.2× 142 0.7× 64 2.5k
William B. Kannel United States 13 416 0.6× 506 1.4× 100 0.4× 35 0.2× 384 1.9× 13 2.1k
Z Písa Czechia 14 569 0.8× 395 1.1× 147 0.7× 22 0.1× 262 1.3× 46 1.9k
Wm. James Howard United States 19 767 1.0× 1.0k 2.7× 93 0.4× 38 0.2× 327 1.6× 47 2.4k
Margot J. Mellies United States 31 1.3k 1.8× 1.6k 4.4× 178 0.8× 76 0.4× 705 3.5× 81 3.0k

Countries citing papers authored by John Reckless

Since Specialization
Citations

This map shows the geographic impact of John Reckless's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Reckless with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Reckless more than expected).

Fields of papers citing papers by John Reckless

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Reckless. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Reckless. The network helps show where John Reckless may publish in the future.

Co-authorship network of co-authors of John Reckless

This figure shows the co-authorship network connecting the top 25 collaborators of John Reckless. A scholar is included among the top collaborators of John Reckless based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Reckless. John Reckless is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Scutt, Polly, D. Blackburn, Kailash Krishnan, et al.. (2015). Baseline characteristics, analysis plan and report on feasibility for the Prevention Of Decline in Cognition After Stroke Trial (PODCAST). Trials. 16(1). 509–509. 5 indexed citations
3.
4.
Lean, Michael E. J., Naomi Brosnahan, Philip McLoone, et al.. (2013). Feasibility and indicative results from a 12-month low-energy liquid diet treatment and maintenance programme for severe obesity. British Journal of General Practice. 63(607). e115–e124. 63 indexed citations
5.
Reckless, John, Glenn Davies, Kaan Tunceli, Xiaohan Hu, & Philippe Brudi. (2010). Projected Cost-Effectiveness of Ezetimibe/Simvastatin Compared with Doubling the Statin Dose in the United Kingdom: Findings from the INFORCE Study. Value in Health. 13(6). 726–734. 20 indexed citations
6.
Trueman, Paul, Sarah M. Haynes, H. M. Ross, et al.. (2010). Long-term cost-effectiveness of weight management in primary care. International Journal of Clinical Practice. 64(6). 775–783. 51 indexed citations
7.
Brudi, Philippe, John Reckless, Sanghyun Lim, et al.. (2008). Efficacy of Ezetimibe/Simvastatin 10/40 mg Compared to Doubling the Dose of Low-, Medium- and High-Potency Statin Monotherapy in Patients with a Recent Coronary Event. Cardiology. 113(2). 89–97. 4 indexed citations
8.
Reckless, John, Peter J. Henry, Sanghyun Lim, et al.. (2008). Lipid-altering efficacy of ezetimibe/simvastatin 10/40 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: the INFORCE study. International Journal of Clinical Practice. 62(4). 539–554. 28 indexed citations
9.
Leiter, Lawrence A., Robert S. Rosenson, Evan A. Stein, et al.. (2007). Efficacy and safety of rosuvastatin 40mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: Results of the POLARIS study. Atherosclerosis. 194(2). e154–e164. 51 indexed citations
10.
Broom, J., Jenny Brown, Rachel Laws, et al.. (2005). The impact of obesity on drug prescribing in primary care. British Journal of General Practice. 55(519). 743–749. 53 indexed citations
11.
Mukhtar, Rasha, et al.. (2005). Pitavastatin. International Journal of Clinical Practice. 59(2). 239–252. 128 indexed citations
12.
Mukhtar, Rasha & John Reckless. (2005). Statin-induced myositis: a commonly encountered or rare side effect?. Current Opinion in Internal Medicine. 5(1). 34–41. 44 indexed citations
13.
Lawrence, Jean M., et al.. (2004). The effect of high dose atorvastatin therapy on lipids and lipoprotein subfractions in overweight patients with type 2 diabetes. Atherosclerosis. 174(1). 141–149. 12 indexed citations
14.
Lawrence, Jean M., et al.. (2003). Favourable effects of pioglitazone and metformin on LDL subfractions in type 2 diabetes. Atherosclerosis. 169(2). 358–358. 1 indexed citations
15.
Kozka, I J, A E Clark, John Reckless, et al.. (1995). The effects of insulin on the level and activity of the GLUT4 present in human adipose cells. Diabetologia. 38(6). 661–666. 5 indexed citations
16.
Reckless, John, et al.. (1994). Severe anaphylactic reaction to latex rubber surgical gloves. BMJ. 308(6923). 246–247. 17 indexed citations
17.
Laker, M F, et al.. (1992). Facilities for the management of patients with lipid disorders in the United Kingdom: results of the British Hyperlipidaemia Association Survey.. PubMed. 23(4). 147–9. 2 indexed citations
18.
Reckless, John. (1991). Health economics: the challenge for cardiovascular disease. International Journal of Clinical Practice. 45(2). 163–165. 1 indexed citations
19.
Shepherd, J., D. J. Betteridge, P.N. Durrington, et al.. (1987). Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association.. BMJ. 295(6608). 1245–1246. 92 indexed citations
20.
Reckless, John, et al.. (1985). Glycation of very low density lipoproteins in diabetes.. PubMed. 13. 130–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S.M. Sadikot Breakdown of academic impact, for papers by P.N. Durrington Breakdown of academic impact, for papers by Andrew M. Tershakovec Breakdown of academic impact, for papers by Alice Dowdy Breakdown of academic impact, for papers by Anna Tavridou Breakdown of academic impact, for papers by Kathleen Wyne Breakdown of academic impact, for papers by William B. Kannel Breakdown of academic impact, for papers by Z Písa Breakdown of academic impact, for papers by Wm. James Howard Breakdown of academic impact, for papers by Margot J. Mellies
Rankless by CCL
2026